Effect of Electroacupuncture on Benign Prostatic Hyperplasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age40-80
SponsorGuang'anmen Hospital of China Academy of Chinese Medical Sciences

About this trial

The study aims to assess the efficacy and safety of electroacupuncture among men with benign prostatic hyperplasia (BPH), compared with sham electroacupuncture.

Eligibility criteria

Qualifiers

Diagnosis of BPH in accordance with the European Association of Urology (EAU) guideline;

Male participants aged between 40 and 80 years;

Lower urinary tract symptoms (LUTS) for at least three months;

IPSS total score ≥8;

Disqualifiers

Post-void residual urine volume (PVR) ≥150 mL;

Acute urinary retention or catheterization for outflow obstruction within the 3 months (Except for post-surgical disposable catheterization);

Prostate cancer or prostate-specific antigen (PSA) level ≥4.0 ng/mL;

Neurogenic lower urinary tract dysfunction; prostatitis; uncontrolled symptomatic urinary tract infections; urethral strictures; bladder diverticula; bladder stones; bladder cancer; history of genitourinary system surgery (prostate, bladder, urethra, etc.);

Trial design

Treatments tested in this trial

  • Electroacupuncture
  • Sham electroacupuncture

Treatment groups

306 Participants
are divided into 2 treatment groups